Every day, we sift through the filings to spot where the real conviction lies β cutting through the noise to highlight the most meaningful insider moves.
π International Paper $IP β Director Christopher Connor purchased $1.01 Million via Form 4.
Board-level follow-through buying in a cyclical packaging name as price continues to churn in the middle of a well-defined range.
π Crane Co $CR β Chairman, President, and CEO as well as multiple directors bought $987,470 per new Form 4s.
Cluster buying from the very top tends to matter. This comes as shares stabilize near a key area of interest after a sharp corrective move.
Hereβs The Hot Corner, with data from February 2, 2026:
π Pearson $PSO β Cevian Capital increased its stake from 15.40% to 16.63% in a 13D filing.
The activist keeps pressing its bet as the global education and publishing company tests a major polarity zone thatβs defined price for years.
π Supernus Pharmaceuticals $SUPN β Millennium Management filed a new 13G at 5.30%.
A fresh position from a large multi-strategy fund in a specialty pharma name tightening up just beneath the upper bounds of a massive multi-year base.
